Cambridge Investment Research Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.53M | Sell |
|
|||||
|
2025
Q2 | $7.71M | Buy |
|
|||||
|
2025
Q1 | $7.92M | Buy |
|
|||||
|
2024
Q4 | $5.07M | Sell |
|
|||||
|
2024
Q3 | $6.75M | Buy |
|
|||||
|
2024
Q2 | $6.53M | Sell |
|
|||||
|
2024
Q1 | $7.81M | Buy |
|
|||||
|
2023
Q4 | $6.45M | Buy |
|
|||||
|
2023
Q3 | $4.54M | Buy |
|
|||||
|
2023
Q2 | $4.59M | Buy |
|
|||||
|
2023
Q1 | $3.96M | Sell |
|
|||||
|
2022
Q4 | $3.89M | Sell |
|
|||||
|
2022
Q3 | $4.18M | Buy |
|
|||||
|
2022
Q2 | $3.95M | Buy |
|
|||||
|
2022
Q1 | $3.38M | Buy |
|
|||||
|
2021
Q4 | $2.68M | Sell |
|
|||||
|
2021
Q3 | $2.22M | Sell |
|
|||||
|
2021
Q2 | $2.68M | Buy |
|
|||||
|
2021
Q1 | $2.62M | Buy |
|
|||||
|
2020
Q4 | $2.19M | Buy |
|
|||||
|
2020
Q3 | $2.4M | Sell |
|
|||||
|
2020
Q2 | $6.34M | Buy |
|
|||||
|
2020
Q1 | $2.53M | Buy |
|
|||||
|
2019
Q4 | $1.87M | Buy |
|
|||||
|
2019
Q3 | $1.25M | Sell |
|
|||||
|
2019
Q2 | $1.36M | Buy |
|
|||||
|
2019
Q1 | $1.35M | Buy |
|
|||||
|
2018
Q4 | $1.17M | Sell |
|
|||||
|
2018
Q3 | $1.44M | Buy |
|
|||||
|
2018
Q2 | $1.02M | Buy |
|
|||||
|
2018
Q1 | $968K | Sell |
|
|||||
|
2017
Q4 | $948K | Sell |
|
|||||
|
2017
Q3 | $1.16M | Buy |
|
|||||
|
2017
Q2 | $823K | Buy |
|
|||||
|
2017
Q1 | $687K | Sell |
|
|||||
|
2016
Q4 | $464K | Sell |
|
|||||
|
2016
Q3 | $550K | Sell |
|
|||||
|
2016
Q2 | $575K | Buy |
|
|||||
|
2016
Q1 | $521K | Sell |
|
|||||
|
2015
Q4 | $987K | Sell |
|
|||||
|
2015
Q3 | $881K | Sell |
|
|||||
|
2015
Q2 | $1.41M | Buy |
|
|||||
|
2015
Q1 | $931K | Sell |
|
|||||
|
2014
Q4 | $1M | Sell |
|
|||||
|
2014
Q3 | $1.05M | Buy |
|
|||||
|
2014
Q2 | $787K | Sell |
|
|||||
|
2014
Q1 | $654K | Sell |
|
|||||
|
2013
Q4 | $1.04M | Sell |
|
|||||
|
2013
Q3 | $1.25M | Buy |
|
|||||
|
2013
Q2 | $1.31M | Buy |
|